KalVista Pharmaceuticals (KALV) - Earnings growth in current year

KALV (KalVista Corp) - company brandmark

KalVista Pharmaceuticals (KALV) is implementing an oral standard of care for hereditary angioedema, replacing injections with tablets. The annual EPS trend captures the market reaction to these changes, where the value of 60.30 serves as a baseline performance metric. Success is driven by transparent scientific management in immunology and an organic growth strategy featuring targeted partnerships to prepare commercial distribution channels.

KALV - KalVista Pharmaceuticals Earnings growth in current year over the range 07/04/2022 - 06/21/2026

Financial and market metric breakdowns for kalvista.com (KALV)

Basic company analysis:KalVista Pharmaceuticals, KALV
Manufactured product of KalVista Pharmaceuticals

This indicator measures the annual growth rate of earnings per share, determining the speed of business capitalization through the discounting of its future cash flows. By analyzing the relative annual growth of earnings per share, an investor assesses the commercial efficiency of implementing unique oral treatments for hereditary angioedema, which transform the scientific authority of KalVista Pharmaceuticals (KALV) into tangible financial results.

Key competitors

Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|SEPN (Septerna Corp) - Earnings per share increase in current year|Earnings growth in current year PVLA (Pieris Corp)|SVRA - Net earnings per share growth this year|RIGL - Earnings per share growth in current year|Earnings per share increase in current year ANAB (AnaptysBio)|ATXS: Earnings growth in current year|ENGN - Expected net earnings per share growth this year|Net earnings per share growth this year RAPT|JBIO: Earnings per share increase in current year|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|KYTX: Earnings per share trend in current year|Earnings growth in current year TLSA (Tiziana Life Sciences, Ltd.)|Expected net earnings per share growth this year Cabaletta Bio Inc (CABA)|ventyxbio.com - Earnings growth in current year|Earnings per share growth rate in current year theratech.com|AVTX: Earnings growth in current year|ELDN: Net earnings per one share growth for the current year|AGEN (Agenus, Inc) - Earnings growth in current year|Climb Bio, Inc. - Earnings per share trend in current year|Earnings per share growth in current year Zura Bio (ZURA)|ATYR - Earnings per share growth rate in current year|Earnings per share growth in current year Adagene ADAG|Earnings per share increase in current year IMA|STTK: Net earnings per share growth this year|Earnings per share increase in current year EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Earnings per share growth in current year|Immunic, Inc. (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|X4 Pharmaceuticals Inc. (XFOR) - Earnings per share increase in current year|Net earnings per share growth this year Adicet ACET|Earnings growth in current year CELU (Celularity Inc)|Earnings growth in current year INmune Bio INMB|Barinthus Biotherapeutics plc - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth this year|SAB Biotherapeutics, Inc (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics plc|Earnings per share growth in current year enlivex.com|Earnings per share growth rate in current year q32bio.com QTTB|Earnings per share growth in current year GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Earnings per share increase in current year|Earnings per share growth in current year ibioinc.com IBIO|Earnings growth in current year carismatx.com CARM|XTLB - Earnings per share growth in current year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year